1000 resultados para Restrepo Santamaría, Margaritainés, 1952-2008 - Premios
Resumo:
This report presents a 4-year plan for HIV and AIDS Education and Prevention in Ireland for the period 2008 - 2012. In developing this plan, the Education and Prevention Sub-Committee of the National AIDS Strategy Committee commissioned the National University of Ireland, Galway, to provide a review of:- international publications and policy developments;- the current situation in Ireland in terms of epidemiology, trends and structures;- evidence of best practice in HIV and AIDS prevention and education Download document here
Resumo:
Download document here
Resumo:
Download document here
Resumo:
National Mens Health Policy 2008-2013 Click here to download PDF 1.3mb Reference Document PDF 1.3mb Progress Report PDF 92kb
Resumo:
National Implementation Group (NIG) - European Working Time Directive & Non Consultant Hospital Doctors - Final Report December 2008 Â
Resumo:
Long Stay Activity Report for 2008 Click here to download PDF 2.7mb
Resumo:
Annual Report 2008 Click here to download PDF 276mb
Resumo:
Department of Health and Children Six Monthly Report to the Oireachtas on Developments in the European Union July-December, 2008 Click here to download PDF 119kb
Resumo:
Department of Health and Children Corporate Business Plan 2008 Click here to download PDF 552kb
Resumo:
 Annual Report of the Elder Abuse National Implementation Group (EANIG) 2007/2008 Click here to download PDF 2.0mb
Resumo:
2008 Annual Report of the Alcohol Marketing Communications Monitoring Body Click here to download PDF 158kb
Resumo:
Immunisation Guidelines for Ireland 2008 EDITION – Online only update August 2010 Click here to download PDF 1.73MB
Resumo:
HIV and AIDS Education & Prevention Plan 2008 – 2012 – Mid-Term Review Click here to download The Executive Summary PDF 62KB Click here to download The Full Document PDF 299KB
Resumo:
The systematic collection of behavioural information is an important component of second-generation HIV surveillance. The extent of behavioural surveillance among injecting drug users (IDUs) in Europe was examined using data collected through a questionnaire sent to all 31 countries of the European Union and European Free Trade Association as part of a European-wide behavioural surveillance mapping study on HIV and other sexually transmitted infections. The questionnaire was returned by 28 countries during August to September 2008: 16 reported behavioural surveillance studies (two provided no further details). A total of 12 countries used repeated surveys for behavioural surveillance and five used their Treatment Demand Indicator system (three used both approaches). The data collected focused on drug use, injecting practices, testing for HIV and hepatitis C virus and access to healthcare. Eight countries had set national indicators: three indicators were each reported by five countries: the sharing any injecting equipment, uptake of HIV testing and uptake of hepatitis C virus testing. The recall periods used varied. Seven countries reported conducting one-off behavioural surveys (in one country without a repeated survey, these resulted an informal surveillance structure). All countries used convenience sampling, with service-based recruitment being the most common approach. Four countries had used respondent-driven sampling. Three fifths of the countries responding (18/28) reported behavioural surveillance activities among IDUs; however, harmonisation of behavioural surveillance indicators is needed.
Resumo:
Im Rahmen der Zusammenarbeit zwischen dem Walliser Krebsregister (WKR), dem Walliser Gesundheitsobservatorium (WGO) und dem Walliser Departement Onkologie wurde beschlossen, eine Studie über die Epidemiologie und die Behandlung von Brustkrebs im Wallis zwischen 2008 und 2010 durchzuführen. Ziel dieser Studie ist es, die Häufigkeit, die Art der Entdeckung, die Behandlungen sowie die 1- und 2-JahresÜberlebensraten von Brustkrebs im Wallis zu beschreiben. Brustkrebs ist die häufigste Krebserkrankung und die zweithäufigste Krebstodesursache bei den Frauen im Wallis. Zwischen 2008 und 2010 wurden im Wallis 836 Fälle von Brustkrebs diagnostiziert. 90% der Karzinome sind invasiv und 10% in situ. Das Durchschnittsalter bei der Diagnosestellung beträgt 62 Jahre. 10% der Karzinome befinden sich im Stadium 0 (Carcinoma in situ), 38% im Stadium I, 36% im Stadium II, 10% im Stadium III und 4% im Stadium IV. 55% der Fälle werden durch ein individuelles (31%) oder organisiertes (23%) Screening entdeckt. 78% der Fälle werden an einem Tumorboard besprochen.